BeOne Medicines Ltd. (ONC) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2022 | $286.48M | +73.7% |
| 2021 | $164.91M | +133.4% |
| 2020 | $70.66M | -0.7% |
| 2019 | $71.19M | +148.0% |
| 2018 | $28.70M | +477.1% |
| 2017 | $4.97M | — |
| 2016 | $0 | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2022 | $286.48M | +73.7% |
| 2021 | $164.91M | +133.4% |
| 2020 | $70.66M | -0.7% |
| 2019 | $71.19M | +148.0% |
| 2018 | $28.70M | +477.1% |
| 2017 | $4.97M | — |
| 2016 | $0 | — |